| Net Cash Provided by (Used in) Operating Activities |
-144,042,000 |
USD |
-61.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
226,352,000 |
USD |
+24.7% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
499,950,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
128,852,866 |
shares |
+44% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
82,310,000 |
USD |
-10.9% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
166,274,000 |
USD |
+64.7% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
18,799,000 |
USD |
-31% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
2,654,974,000 |
USD |
+44.3% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
92,898,000 |
USD |
+80.9% |
Q1 2024 |
Q1 2024 |